您当前的位置：
首页 >
文章列表页 >
FAPI in radionuclide theranostics: toward a new emerging paradigm for tumor management
更新时间：2025-12-15

    • FAPI in radionuclide theranostics: toward a new emerging paradigm for tumor management

    • “The latest research shows that fibroblast activation protein inhibitors have made breakthroughs in the field of pan tumor diagnosis and treatment, and are expected to promote the formation of a new paradigm of nuclear diagnosis and treatment.”
    • Oncoradiology   Vol. 34, Issue 5, Pages: 444-453(2025)

    • DOI：10.19732/j.cnki.2096-6210.2025.05.002    

      CLC：

    • Received：12 September 2025，

      Published Online：06 November 2025，

      Published：28 October 2025

    移动端阅览

  • Ying DING, Hui YANG. FAPI in radionuclide theranostics: toward a new emerging paradigm for tumor management[J]. Oncoradiology, 2025, 34(5): 444-453. DOI： 10.19732/j.cnki.2096-6210.2025.05.002.

  •  
  •  

0

Views

67

下载量

0

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Advances in FAP-targeted molecular imaging probes for disease detection
Research advances in EphA2-targeted theranostic radiopharmaceuticals
64Cu/177Lu-DOTA-diZD, a small-molecule-based theranostic pair for triple-negative breast cancer
Research progress in the application of T1 mapping technology in tumor lesions
Comparison of 18F-FDG PET/CT and 68Ga-FAPI PET/CT in diagnosis of different types of lymphoma

Related Author

SONG Shaoli
XU Xiaoping
WANG Xiao
Shaoli SONG
Xiaoping XU
Xinyu LIU
Wei FAN
Yuqian HUANG

Related Institution

Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Fudan University
Shanghai Engineering Research Center of Molecular Imaging Probes
Center for Biomedical Imaging, Fudan University
Department of Nuclear Medicine, Sun Yat-sen University Cancer Centre
0